Pharmacokinetics and pharmacodynamics of single and multiple-dose levamisole in belugas (Huso huso): Main focus on immunity responses.
Beluga sturgeon
Bioavailability
Immunostimulation
Levamisole
Pharmacokinetics
Journal
Fish & shellfish immunology
ISSN: 1095-9947
Titre abrégé: Fish Shellfish Immunol
Pays: England
ID NLM: 9505220
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
18
12
2020
revised:
15
04
2021
accepted:
17
04
2021
pubmed:
30
4
2021
medline:
10
7
2021
entrez:
29
4
2021
Statut:
ppublish
Résumé
The pharmacokinetics of levamisole were determined in the belugas after single intravascular (IV), and single and multiple-dose oral by feed administrations. Also, the effect of levamisole (LVM) on the stress and immune responses of belugas were assessed. One hundred-fourteen healthy belugas in 4 different groups received single LVM administration at the doses of 50 and 100 mg/kg via IV and oral routes. A separate group of 24 belugas were administered oral LVM at the dose of 100 mg/kg for 5 days. Blood samples were collected at different time points after administrations to measure plasma concentrations of LVM by a validated high-performance liquid chromatography (HPLC) assay. For immunological evaluations, a total of 126 belugas received 50 and 100 mg/kg LVM via medicated feed for 5 days or served as the control without any medication; blood samples were recovered on day 0, 1, 3, 5, 7, 10, and 14 to measure hemolytic activity of the complement system (HAC
Identifiants
pubmed: 33915293
pii: S1050-4648(21)00106-6
doi: 10.1016/j.fsi.2021.04.016
pii:
doi:
Substances chimiques
Antinematodal Agents
0
Levamisole
2880D3468G
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
152-160Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.